Headquartered in Minnesota, Fasikl is a neuro-AI firm on a mission to advance neurotherapies, offering transformative treatments designed to significantly improve patient well-being. Utilizing proprietary technology, Fasikl’s products acquire neural signals at both the fascicle and fiber levels, enabling the simultaneous recording of comprehensive neural data. This data serves as the foundation for AI-guided therapeutic approaches. Drawing on extensive research and experience, the company foresees a major shift towards intelligent bioelectronic medicine, where artificial intelligence will take a pivotal role in optimizing therapy management for improved patient outcomes.
